Age and Outcomes of Early Rhythm Control in Patients With Atrial Fibrillation

Abstract

This study sought to investigate whether the effects of early rhythm control differ according to age. Rhythm control, compared with usual care among patients recently diagnosed with atrial fibrillation (AF), was found to be associated with a lower risk of adverse cardiovascular outcomes. It is unclear whether the results can be generalized for older adults. This retrospective population-based cohort study included 31,220 patients with AF, from the Korean National Health Insurance Service database, undergoing rhythm control (antiarrhythmic drugs or ablation) or rate control therapy, initiated within 1 year of AF diagnosis. A composite outcome of cardiovascular death, ischemic stroke, hospitalization for heart failure, or myocardial infarction was compared in subgroups stratified by age. Compared with rate control, early rhythm control was associated with a lower risk of the primary composite outcome in patients<75 years of age (HR: 0.80; 95%CI: 0.72-0.88). The protective association between early rhythm control and cardiovascular outcomes exhibited a linear decrease with advancing age, with declined benefits in patients≥75 years of age (HR: 0.94; 95%CI: 0.87-1.03; Pinteraction=0.045). Trends toward lower risks of ischemic stroke (HR: 0.78; 95%CI: 0.67-0.90) and acute myocardial infarction (HR: 0.63; 95%CI: 0.41-0.97) were observed in the older adults. No significant differences in safety outcomes were found across different ages. The beneficial association of early rhythm control with cardiovascular outcomes was attenuated with increasing age, with the larger benefits in younger patients<75 years of age. No differences were found by age in treatment-related safety outcomes.